Breaking News
Investing Pro 0
Cyber Monday Extended SALE: Up to 60% OFF InvestingPro+ CLAIM OFFER

Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session

Stock Markets Sep 30, 2022 17:40
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session
 
CCL
-4.02%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
IXIC
-0.18%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
CCL
+0.30%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
C1CL34
-1.06%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Gainers

  • Ainos, Inc. (NASDAQ: AIMD) shares surged 55.1% to $2.1411 after the company reported results from the additional preclinical study of its low-dose oral interferon formulation against Omicron. The company reported VELDONA formulation showed significant stabilization of physical condition and complete recovery from lung inflammation throughout the course of treatment period.
  • F45 Training Holdings Inc. (NYSE: FXLV) shares jumped 43.1% to $3.1350 after a 13D filing showed the company received a non-binding proposal offer by one or more funds for a value of $4 per share.
  • InMed Pharmaceuticals Inc. (NASDAQ: INM) gained 39.9% to $8.03. InMed recently reported a FY22 net loss of $33.17 per share.
  • SOBR Safe, Inc. (NASDAQ: SOBR) jumped 39.3% to $2.6884 after the company announced it signed three reseller agreements with national distributors.
  • MoneyLion Inc. (NYSE: ML) rose 28% to $1.02. MoneyLion responded to Consumer Financial Protection Bureau’s meritless complaint.
  • FingerMotion, Inc. (NASDAQ: FNGR) surged 23.1% to $2.2778.
  • O2Micro International Limited (NASDAQ: OIIM) rose 22.8% to $3.9901 after the company announced it entered into a definitive agreement for a "going private" transaction.
  • Avenue Therapeutics, Inc. (NASDAQ: ATXI) shares gained 22.6% to $8.89. The stock has been volatile after the company last week announced a 1-for-15 reverse split and received meeting minutes from the FDA regarding a meeting conducted on August 9, 2022, for IV Tramadol.
  • IGM Biosciences, Inc. (NASDAQ: IGMS) rose 18.9% to $23.11.
  • X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) gained 18.8% to $1.77. X4 Pharmaceuticals recently announced data from its Phase 1b trial evaluating mavorixafor in chronic neutropenia.
  • Benson Hill, Inc. (NYSE: BHIL) rose 18.3% to $2.9250 after UBS initiated coverage on the stock with a Buy rating and $5 price target.
  • Tyra Biosciences, Inc. (NASDAQ: TYRA) jumped 17.7% to $10.33.
  • Alset EHome International Inc. (NASDAQ: AEI) gained 17.3% to $0.2299.
  • Snow Lake Resources Ltd. (NASDAQ: LITM) surged 16.7% to $1.8215. Snow Lake Resources issued filing showing the company has requested for withdrawal of registration statement in regards to its previously announced public offering.
  • Nocera, Inc. (NASDAQ: NCRA) jumped 16.2% to $1.58. Nocera recently entered into agreement to acquire 51% controlling interest in iTake Inc. in Taiwan.
  • Ecoark Holdings, Inc. (NASDAQ: ZEST) gained 14.8% to $1.47.
  • SAI.TECH Global Corporation (NASDAQ: SAI) rose 14.6% to $2.59 after dipping 26% on Thursday. SAI.TECH recently announced the launch of new liquid cooling Bitcoin mining infrastructure products.
  • Solid Biosciences Inc. (NASDAQ: SLDB) gained 14.4% to $0.5355 after the company announced acquisition of AavantiBio and a concurrent $75 million private placement.
  • Akero Therapeutics, Inc. (NASDAQ: AKRO) rose 14.3% to $34.06. Akero Therapeutics recently released topline data from HARMONY Phase 2b study of efruxifermin (EFX) in patients with pre-cirrhotic nonalcoholic steatohepatitis (NASH), fibrosis stage 2 or 3 (F2-F3).
  • IonQ, Inc. (NYSE: IONQ) gained 13.3% to $5.41after the company announced it secured a contract to provide quantum solutions to the U.S. Air Force Research Lab.
  • Immuneering Corporation (NASDAQ: IMRX) jumped 12.6% to $14.77. Immuneering announced FDA clearance of IND application for Phase 1/2a clinical trial of IMM-1-104 to treat advanced solid tumors with RAS mutations.
  • bluebird bio, Inc. (NASDAQ: BLUE) gained 12.2% to $6.39. bluebird bio recently named Katherine Breedis as interim CFO.
  • Foghorn Therapeutics Inc. (NASDAQ: FHTX) jumped 11.2% to $9.13.
  • MINISO Group Holding Limited (NYSE: MNSO) surged 11% to $5.53. MINISO Group’s board of directors recently authorized and approved a new share repurchase program.
  • Daseke, Inc. (NASDAQ: DSKE) gained 10.5% to $5.41 after the company announced a $40 million stock repurchase program.
  • Iveda Solutions, Inc. (NASDAQ: IVDA) rose 9.9% to $0.67 after declining over 6% on Thursday. Iveda Solutions, last month, announced a $5 million private placement.
  • Kura Oncology, Inc. (NASDAQ: KURA) gained 9.2% to $14.53. Kura Oncology, last month, posted a Q2 loss of $0.52 per share.
  • Paysafe Limited (NASDAQ: PSFE) gained 8.8% to $1.48.
  • Charles River Laboratories International, Inc. (NYSE: CRL) gained 7.6% to $204.46 after Jefferies upgraded the stock from Hold to Buy and announced a $240 price target.
  • WISeKey International Holding AG (NASDAQ: WKEY) rose 7.3% to $1.6101.
  • First Wave BioPharma, Inc. (NASDAQ: FWBI) rose 6.2% to $1.54.
Losers
  • Antelope Enterprise Holdings Limited (NASDAQ: AEHL) shares dipped 36.7% to $0.57 after the company announced pricing of a $1 million registered direct offering.
  • American Virtual Cloud Technologies, Inc. (NASDAQ: AVCT (LON:AVCT)) fell 36.4% to $ 0.1899. AVCT announced intent to effect reverse stock split.
  • SHF Holdings Inc (NASDAQ: SHFS) fell 23% to $6.73 after declining 15% on Thursday. Northern Lights Acquisition completed business combination of SHF, Safe Harbor Financial, which offers compliance services to financial institutions that serve the regulated cannabis industry.
  • 5E Advanced Materials Inc. (NASDAQ: FEAM) dropped 22.8% to $10.82.
  • Aterian, Inc. (NASDAQ: ATER) fell 20.3% to $1.5708 after the company priced a 10,526,368 share registered direct offering at $1.90 per share
  • Carnival Corporation (NYSE: NYSE:CCL) fell 19% to $6.73 after the company reported worse-than-expected Q3 EPS and sales results.
  • Panbela Therapeutics, Inc. (NASDAQ: PBLA) dropped 17.8% to $0.2951 after the company priced a common stock offering of 20.1 million shares at $0.30 per share.
  • Rent-A-Center Inc (NASDAQ: RCII) fell 17.3% to $18.46 as the company lowered its earnings guidance for the third quarter and named Mr. Fahmi Karam as new Executive Vice President - Chief Financial Officer.
  • Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) dipped 16.1% to $0.4997.
  • Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) shares fell 15% to $13.96 after the company announced its REVERSE Phase 3 study of obeticholic acid did not meet its primary endpoint.
  • OpGen, Inc. (NASDAQ: OPGN) fell 15% to $0.3201 after the company announced a $3.38 million registered direct offering.
  • TH International Ltd (NASDAQ: THCH) declined 12.7% to $6.36.
  • Norwegian Cruise Line Holdings Ltd. (NASDAQ: NCLH) dropped 12% to $12.21 in sympathy with Carnival, which fell after the company reported worse-than-expected Q3 financial results.
  • Century Aluminum Company (NASDAQ: CENX) dipped 12% to $5.68 after Wolfe Research downgraded the stock from Peer Perform to Underperform.
  • NIKE, Inc. (NYSE: NKE) fell 10.5% to $85.28. NIKE reported better-than-expected earnings and sales results for its first quarter on Thursday. However, the company reported a rise in quarter-ended inventories and revenue in the Greater China region also declined from a year ago.
  • Ocular Therapeutix, Inc. (NASDAQ: OCUL) dropped 10.3% to $4.60. Ocular Therapeutix 10%+ owner Summer Road LLC reported purchase of 150,000 at an average price of $4.59 per share in Form 4 filing on Thursday.
  • Royal Caribbean Cruises Ltd. (NYSE: RCL) fell 8.7% to $39.84 in sympathy with Carnival, which fell after the company reported worse-than-expected Q3 financial results.
  • Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) fell 5% to $28.69 as the stock pulled back after gaining following FDA approval of RELYVRIO for ALS..
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email